About Bleomycin Sulfate
            
            Class: | Antineoplastic agent, Antibiotic  
Use: | Treatment of various cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and certain types of squamous cell carcinoma.  
Adult dose: | Typically, 15-30 units/m² IV or IM once every 1-3 weeks, depending on the specific cancer and treatment protocol.  
Pediatric dose: | Dosing is individualized based on body surface area; generally, 10-20 units/m² IV or IM every 1-3 weeks.  
Side effects: | Common side effects include 
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Antibiotic
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of various cancers including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, and certain types of squamous cell carcinoma.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from light and moisture. Reconstituted solutions should be used promptly or stored in the refrigerator for a limited time.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Willow Pharmaceuticals, AUSTRALIA
                    
                    
                    Package Size
                    1 Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 138.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Typically, 15-30 units/m² IV or IM once every 1-3 weeks, depending on the specific cancer and treatment protocol.
                    
                    
                        Pediatric Dose
                    
                    
                        Dosing is individualized based on body surface area; generally, 10-20 units/m² IV or IM every 1-3 weeks.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include fever, chills, nausea, vomiting, skin reactions (such as rash or ulceration), and pulmonary toxicity.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to bleomycin, history of pulmonary fibrosis, severe lung disease, and pregnancy (unless clearly needed).
         
        
        
            
                Important Warnings
            
            Risk of pulmonary toxicity, especially in patients with pre-existing lung conditions or those receiving high doses; monitor lung function regularly. Avoid use in patients with renal impairment as clearance may be reduced.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.